One Gene announced that it has raised a round of funding on December 8, 2023. The transaction included participation from ChengDa Pharmaceuticals Co., Ltd.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19.98 CNY | +1.78% | -0.65% | -21.43% |
May. 14 | ChengDa Pharmaceuticals Co., Ltd. Approves Cash Dividend for 2023 | CI |
Apr. 21 | ChengDa Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-21.43% | 419M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
+9.78% | 210B | |
-5.52% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- 301201 Stock
- News ChengDa Pharmaceuticals Co., Ltd.
- One Gene announced that it has received funding from ChengDa Pharmaceuticals Co., Ltd.